메뉴 건너뛰기




Volumn 6, Issue 26, 2015, Pages 22624-22640

Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells

Author keywords

Cancer therapy; Cell activation; Cell proliferation; Chronic lymphocytic leukemia; Metformin

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR CXCR4; FLUDARABINE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; METFORMIN; PROTEIN KINASE B; PROTEIN MCL 1; STAT3 PROTEIN; ANTIDIABETIC AGENT;

EID: 84941204952     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4168     Document Type: Article
Times cited : (33)

References (92)
  • 6
    • 33947389299 scopus 로고    scopus 로고
    • Highly purified CD38+ and CD38-sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin
    • Pepper C, Ward R, Lin TT, Brennan P, Starczynski J, Musson M, Rowntree C, Bentley P, Mills K, Pratt G, Fegan C. Highly purified CD38+ and CD38-sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia. 2007; 21:687-696.
    • (2007) Leukemia , vol.21 , pp. 687-696
    • Pepper, C.1    Ward, R.2    Lin, T.T.3    Brennan, P.4    Starczynski, J.5    Musson, M.6    Rowntree, C.7    Bentley, P.8    Mills, K.9    Pratt, G.10    Fegan, C.11
  • 9
    • 0026427043 scopus 로고
    • Growing human B lymphocytes in the CD40 system
    • Banchereau J, Rousset F. Growing human B lymphocytes in the CD40 system. Nature. 1991; 353:678-679.
    • (1991) Nature , vol.353 , pp. 678-679
    • Banchereau, J.1    Rousset, F.2
  • 10
    • 34547998715 scopus 로고    scopus 로고
    • Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia
    • Willimott S, Baou M, Huf S, Wagner SD. Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia. Leuk Lymphoma. 2007; 48:1647-1650.
    • (2007) Leuk Lymphoma , vol.48 , pp. 1647-1650
    • Willimott, S.1    Baou, M.2    Huf, S.3    Wagner, S.D.4
  • 11
    • 33745984491 scopus 로고    scopus 로고
    • Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia
    • author reply 3219-3220
    • Shanafelt TD, Jelinek D, Tschumper R, Schwager S, Nowakowski G, DeWald GW, Kay NE. Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia. J Clin Oncol. 2006; 24:3218-3219; author reply 3219-3220.
    • (2006) J Clin Oncol , vol.24 , pp. 3218-3219
    • Shanafelt, T.D.1    Jelinek, D.2    Tschumper, R.3    Schwager, S.4    Nowakowski, G.5    DeWald, G.W.6    Kay, N.E.7
  • 13
    • 84876334434 scopus 로고    scopus 로고
    • Association of metformin use with cancer incidence and mortality: a metaanalysis
    • Zhang P, Li H, Tan X, Chen L, Wang S. Association of metformin use with cancer incidence and mortality: a metaanalysis. Cancer Epidemiol. 2013; 37:207-218.
    • (2013) Cancer Epidemiol , vol.37 , pp. 207-218
    • Zhang, P.1    Li, H.2    Tan, X.3    Chen, L.4    Wang, S.5
  • 14
    • 84859029647 scopus 로고    scopus 로고
    • Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
    • Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care. 2012; 35:299-304.
    • (2012) Diabetes Care , vol.35 , pp. 299-304
    • Currie, C.J.1    Poole, C.D.2    Jenkins-Jones, S.3    Gale, E.A.4    Johnson, J.A.5    Morgan, C.L.6
  • 17
    • 84883542202 scopus 로고    scopus 로고
    • Potential applications for biguanides in oncology
    • Pollak M. Potential applications for biguanides in oncology. J Clin Invest. 2013; 123:3693-3700.
    • (2013) J Clin Invest , vol.123 , pp. 3693-3700
    • Pollak, M.1
  • 18
    • 0034614420 scopus 로고    scopus 로고
    • Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
    • El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. 2000; 275:223-228.
    • (2000) J Biol Chem , vol.275 , pp. 223-228
    • El-Mir, M.Y.1    Nogueira, V.2    Fontaine, E.3    Averet, N.4    Rigoulet, M.5    Leverve, X.6
  • 20
    • 78650510609 scopus 로고    scopus 로고
    • mTOR: from growth signal integration to cancer, diabetes and ageing
    • Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12:21-35.
    • (2011) Nat Rev Mol Cell Biol , vol.12 , pp. 21-35
    • Zoncu, R.1    Efeyan, A.2    Sabatini, D.M.3
  • 21
    • 84897036925 scopus 로고    scopus 로고
    • The anti-proliferative effect of metformin in triplenegative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention
    • Zordoky BN, Bark D, Soltys CL, Sung MM, Dyck JR. The anti-proliferative effect of metformin in triplenegative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Biochim Biophys Acta. 2014; 1840:1943-1957.
    • (2014) Biochim Biophys Acta , vol.1840 , pp. 1943-1957
    • Zordoky, B.N.1    Bark, D.2    Soltys, C.L.3    Sung, M.M.4    Dyck, J.R.5
  • 22
    • 70749106139 scopus 로고    scopus 로고
    • Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
    • Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. Gynecol Oncol. 2010; 116:92-98.
    • (2010) Gynecol Oncol , vol.116 , pp. 92-98
    • Cantrell, L.A.1    Zhou, C.2    Mendivil, A.3    Malloy, K.M.4    Gehrig, P.A.5    Bae-Jump, V.L.6
  • 26
    • 84860317111 scopus 로고    scopus 로고
    • Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
    • Sikka A, Kaur M, Agarwal C, Deep G, Agarwal R. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle. 2012; 11:1374-1382.
    • (2012) Cell Cycle , vol.11 , pp. 1374-1382
    • Sikka, A.1    Kaur, M.2    Agarwal, C.3    Deep, G.4    Agarwal, R.5
  • 32
    • 84867401438 scopus 로고    scopus 로고
    • N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity
    • Bruno S, Ghiotto F, Tenca C, Mazzarello AN, Bono M, Luzzi P, Casciaro S, Recchia A, Decensi A, Morabito F, Fais F. N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity. Leukemia. 2012; 26:2260-2268.
    • (2012) Leukemia , vol.26 , pp. 2260-2268
    • Bruno, S.1    Ghiotto, F.2    Tenca, C.3    Mazzarello, A.N.4    Bono, M.5    Luzzi, P.6    Casciaro, S.7    Recchia, A.8    Decensi, A.9    Morabito, F.10    Fais, F.11
  • 33
    • 0036124281 scopus 로고    scopus 로고
    • Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27
    • Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia. 2002; 16:327-334.
    • (2002) Leukemia , vol.16 , pp. 327-334
    • Decker, T.1    Schneller, F.2    Hipp, S.3    Miething, C.4    Jahn, T.5    Duyster, J.6    Peschel, C.7
  • 34
    • 0029849620 scopus 로고    scopus 로고
    • Cancer cell cycles
    • Sherr CJ. Cancer cell cycles. Science. 1996; 274:1672-1677.
    • (1996) Science , vol.274 , pp. 1672-1677
    • Sherr, C.J.1
  • 35
    • 58249100053 scopus 로고    scopus 로고
    • CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
    • Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia. 2009; 23:43-52.
    • (2009) Leukemia , vol.23 , pp. 43-52
    • Burger, J.A.1    Peled, A.2
  • 37
    • 0028325968 scopus 로고
    • Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia
    • Kimby E, Rincon J, Patarroyo M, Mellstedt H. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia. Leuk Lymphoma. 1994; 13:297-306.
    • (1994) Leuk Lymphoma , vol.13 , pp. 297-306
    • Kimby, E.1    Rincon, J.2    Patarroyo, M.3    Mellstedt, H.4
  • 38
    • 79960002693 scopus 로고    scopus 로고
    • An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease
    • Giannoni P, Scaglione S, Quarto R, Narcisi R, Parodi M, Balleari E, Barbieri F, Pattarozzi A, Florio T, Ferrini S, Corte G, de Totero D. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica. 2011; 96:1015-1023.
    • (2011) Haematologica , vol.96 , pp. 1015-1023
    • Giannoni, P.1    Scaglione, S.2    Quarto, R.3    Narcisi, R.4    Parodi, M.5    Balleari, E.6    Barbieri, F.7    Pattarozzi, A.8    Florio, T.9    Ferrini, S.10    Corte, G.11    de Totero, D.12
  • 41
    • 0030989818 scopus 로고    scopus 로고
    • CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules
    • Van den Hove LE, Van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, Ceuppens JL. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia. 1997; 11:572-580.
    • (1997) Leukemia , vol.11 , pp. 572-580
    • Van den Hove, L.E.1    Van Gool, S.W.2    Vandenberghe, P.3    Bakkus, M.4    Thielemans, K.5    Boogaerts, M.A.6    Ceuppens, J.L.7
  • 43
    • 70349237504 scopus 로고    scopus 로고
    • B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
    • Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, Gandhi V, Burger JA. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood. 2009; 114:1029-1037.
    • (2009) Blood , vol.114 , pp. 1029-1037
    • Quiroga, M.P.1    Balakrishnan, K.2    Kurtova, A.V.3    Sivina, M.4    Keating, M.J.5    Wierda, W.G.6    Gandhi, V.7    Burger, J.A.8
  • 45
    • 73949119120 scopus 로고    scopus 로고
    • Akt is activated in chronic lymphocytic leukemia cells and delivers a prosurvival signal: the therapeutic potential of Akt inhibition
    • Zhuang J, Hawkins SF, Glenn MA, Lin K, Johnson GG, Carter A, Cawley JC, Pettitt AR. Akt is activated in chronic lymphocytic leukemia cells and delivers a prosurvival signal: the therapeutic potential of Akt inhibition. Haematologica. 2010; 95:110-118.
    • (2010) Haematologica , vol.95 , pp. 110-118
    • Zhuang, J.1    Hawkins, S.F.2    Glenn, M.A.3    Lin, K.4    Johnson, G.G.5    Carter, A.6    Cawley, J.C.7    Pettitt, A.R.8
  • 46
    • 38349107623 scopus 로고    scopus 로고
    • The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells
    • Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood. 2008; 111:846-855.
    • (2008) Blood , vol.111 , pp. 846-855
    • Longo, P.G.1    Laurenti, L.2    Gobessi, S.3    Sica, S.4    Leone, G.5    Efremov, D.G.6
  • 47
    • 33845526567 scopus 로고    scopus 로고
    • The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease
    • Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia. 2007; 21:110-120.
    • (2007) Leukemia , vol.21 , pp. 110-120
    • Longo, P.G.1    Laurenti, L.2    Gobessi, S.3    Petlickovski, A.4    Pelosi, M.5    Chiusolo, P.6    Sica, S.7    Leone, G.8    Efremov, D.G.9
  • 51
    • 84886796988 scopus 로고    scopus 로고
    • Essential role of cooperative NF-kappaB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma
    • Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS. Essential role of cooperative NF-kappaB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene. 2013; 32:5144-5155.
    • (2013) Oncogene , vol.32 , pp. 5144-5155
    • Kesanakurti, D.1    Chetty, C.2    Rajasekhar Maddirela, D.3    Gujrati, M.4    Rao, J.S.5
  • 52
    • 27544494623 scopus 로고    scopus 로고
    • Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation
    • Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res. 2005; 65:9891-9898.
    • (2005) Cancer Res , vol.65 , pp. 9891-9898
    • Kukreja, P.1    Abdel-Mageed, A.B.2    Mondal, D.3    Liu, K.4    Agrawal, K.C.5
  • 54
    • 17144383220 scopus 로고    scopus 로고
    • VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
    • Lee YK, Shanafelt TD, Bone ND, Strege AK, Jelinek DF, Kay NE. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia. 2005; 19:513-523.
    • (2005) Leukemia , vol.19 , pp. 513-523
    • Lee, Y.K.1    Shanafelt, T.D.2    Bone, N.D.3    Strege, A.K.4    Jelinek, D.F.5    Kay, N.E.6
  • 55
    • 84891904194 scopus 로고    scopus 로고
    • Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPKmediated energetic re-programming
    • Martinez Marignac VL, Smith S, Toban N, Bazile M, Aloyz R. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPKmediated energetic re-programming. Oncotarget. 2013; 4:2550-2566.
    • (2013) Oncotarget , vol.4 , pp. 2550-2566
    • Martinez Marignac, V.L.1    Smith, S.2    Toban, N.3    Bazile, M.4    Aloyz, R.5
  • 57
    • 84941204679 scopus 로고    scopus 로고
    • Investigating and Targeting Chronic Lymphocytic Leukemia Metabolism with the HIV Protease Inhibitor Ritonavir and Metformin
    • Adekola KU, Aydemir SD, Ma S, Zhou Z, Rosen ST, Shanmugam M. Investigating and Targeting Chronic Lymphocytic Leukemia Metabolism with the HIV Protease Inhibitor Ritonavir and Metformin. Leuk Lymphoma. 2014:1-23.
    • (2014) Leuk Lymphoma , pp. 1-23
    • Adekola, K.U.1    Aydemir, S.D.2    Ma, S.3    Zhou, Z.4    Rosen, S.T.5    Shanmugam, M.6
  • 58
    • 0034659785 scopus 로고    scopus 로고
    • Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
    • Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000; 348 Pt3:607-614.
    • (2000) Biochem J , vol.348 , pp. 607-614
    • Owen, M.R.1    Doran, E.2    Halestrap, A.P.3
  • 59
    • 84863838332 scopus 로고    scopus 로고
    • Normal and cancer cell metabolism: lymphocytes and lymphoma
    • Altman BJ, Dang CV. Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J. 2012; 279:2598-2609.
    • (2012) FEBS J , vol.279 , pp. 2598-2609
    • Altman, B.J.1    Dang, C.V.2
  • 60
    • 84866870458 scopus 로고    scopus 로고
    • The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state
    • Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CM. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood. 2012; 120:2631-2638.
    • (2012) Blood , vol.120 , pp. 2631-2638
    • Tili, E.1    Michaille, J.J.2    Luo, Z.3    Volinia, S.4    Rassenti, L.Z.5    Kipps, T.J.6    Croce, C.M.7
  • 62
    • 0029915853 scopus 로고    scopus 로고
    • A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli
    • Yoshioka K, Takahashi H, Homma T, Saito M, Oh KB, Nemoto Y, Matsuoka H. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim Biophys Acta. 1996; 1289:5-9.
    • (1996) Biochim Biophys Acta , vol.1289 , pp. 5-9
    • Yoshioka, K.1    Takahashi, H.2    Homma, T.3    Saito, M.4    Oh, K.B.5    Nemoto, Y.6    Matsuoka, H.7
  • 63
    • 25844526509 scopus 로고    scopus 로고
    • 2-NBDG as a fluorescent indicator for direct glucose uptake measurement
    • Zou C, Wang Y, Shen Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods. 2005; 64:207-215.
    • (2005) J Biochem Biophys Methods , vol.64 , pp. 207-215
    • Zou, C.1    Wang, Y.2    Shen, Z.3
  • 65
    • 66149147044 scopus 로고    scopus 로고
    • Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
    • Vogler M, Butterworth M, Majid A, Walewska RJ, Sun XM, Dyer MJ, Cohen GM. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood. 2009; 113:4403-4413.
    • (2009) Blood , vol.113 , pp. 4403-4413
    • Vogler, M.1    Butterworth, M.2    Majid, A.3    Walewska, R.J.4    Sun, X.M.5    Dyer, M.J.6    Cohen, G.M.7
  • 67
    • 20444389401 scopus 로고    scopus 로고
    • Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
    • Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood. 2005; 105:4820-4827.
    • (2005) Blood , vol.105 , pp. 4820-4827
    • Petlickovski, A.1    Laurenti, L.2    Li, X.3    Marietti, S.4    Chiusolo, P.5    Sica, S.6    Leone, G.7    Efremov, D.G.8
  • 70
    • 84928382161 scopus 로고    scopus 로고
    • Targeting AMPK for cancer prevention and treatment
    • Li W, Saud SM, Young MR, Chen G, Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget. 2015; 6:7365-7378.
    • (2015) Oncotarget , vol.6 , pp. 7365-7378
    • Li, W.1    Saud, S.M.2    Young, M.R.3    Chen, G.4    Hua, B.5
  • 72
    • 77949653043 scopus 로고    scopus 로고
    • Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation
    • Pradelli LA, Beneteau M, Chauvin C, Jacquin MA, Marchetti S, Munoz-Pinedo C, Auberger P, Pende M, Ricci JE. Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene. 2010; 29:1641-1652.
    • (2010) Oncogene , vol.29 , pp. 1641-1652
    • Pradelli, L.A.1    Beneteau, M.2    Chauvin, C.3    Jacquin, M.A.4    Marchetti, S.5    Munoz-Pinedo, C.6    Auberger, P.7    Pende, M.8    Ricci, J.E.9
  • 74
    • 0033568454 scopus 로고    scopus 로고
    • Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture
    • Aloj L, Caraco C, Jagoda E, Eckelman WC, Neumann RD. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res. 1999; 59:4709-4714.
    • (1999) Cancer Res , vol.59 , pp. 4709-4714
    • Aloj, L.1    Caraco, C.2    Jagoda, E.3    Eckelman, W.C.4    Neumann, R.D.5
  • 77
    • 11144314179 scopus 로고    scopus 로고
    • Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine
    • Carew JS, Nawrocki ST, Xu RH, Dunner K, McConkey DJ, Wierda WG, Keating MJ, Huang P. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia. 2004; 18:1934-1940.
    • (2004) Leukemia , vol.18 , pp. 1934-1940
    • Carew, J.S.1    Nawrocki, S.T.2    Xu, R.H.3    Dunner, K.4    McConkey, D.J.5    Wierda, W.G.6    Keating, M.J.7    Huang, P.8
  • 79
    • 33845994359 scopus 로고    scopus 로고
    • Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
    • Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, Letai A. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest. 2007; 117:112-121.
    • (2007) J Clin Invest , vol.117 , pp. 112-121
    • Del Gaizo Moore, V.1    Brown, J.R.2    Certo, M.3    Love, T.M.4    Novina, C.D.5    Letai, A.6
  • 80
    • 0026541437 scopus 로고
    • The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes
    • Sum CF, Webster JM, Johnson AB, Catalano C, Cooper BG, Taylor R. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes. Diabet Med. 1992; 9:61-65.
    • (1992) Diabet Med , vol.9 , pp. 61-65
    • Sum, C.F.1    Webster, J.M.2    Johnson, A.B.3    Catalano, C.4    Cooper, B.G.5    Taylor, R.6
  • 86
    • 0028158709 scopus 로고
    • Accumulation of metformin by tissues of the normal and diabetic mouse
    • Wilcock C, Bailey CJ. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica. 1994; 24:49-57.
    • (1994) Xenobiotica , vol.24 , pp. 49-57
    • Wilcock, C.1    Bailey, C.J.2
  • 92
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984; 22:27-55.
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.